Search Login Register
Dihydroxyphenylalanine
(Dopa)
Summary
Description:
A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
Also Known As:
Dopa; 3,4-Dihydroxyphenylalanine; 3-Hydroxy-DL-tyrosine; Dihydroxyphenylalanine Hydrochloride, (2:1); beta-Hydroxytyrosine Show All >>
Networked: 1143
relevant articles (51 outcomes,
102 trials/studies)
for this Bio-Agent
Key Diseases for which Dihydroxyphenylalanine is
Relevant
-
Parkinson Disease (Parkinson's Disease)
:
20 outcomes 19 studies in 240 results
-
Dyskinesias (Dyskinesia)
:
14 outcomes 6 studies in 91 results
-
Neoplasms (Cancer)
:
4 outcomes 7 studies in 58 results
-
Dystonia (Limb Dystonia)
:
4 outcomes 2 studies in 49 results
-
Parkinsonian Disorders (Parkinsonism)
:
3 outcomes 7 studies in 131 results
Show All >>
Drugs Related to Dihydroxyphenylalanine
-
Levodopa (L Dopa)
-
Dopamine (Intropin)
-
Dihydroxyphenylalanine (Dopa)
-
Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
-
Catecholamines
-
Methyldopa (Aldomet)
-
5-Hydroxytryptophan (5 Hydroxytryptophan)
-
Serotonin (5 Hydroxytryptamine)
-
Enzymes
-
3,4-Dihydroxyphenylacetic Acid
Show All >>
Therapies Related to Dihydroxyphenylalanine
-
Drug Therapy (Chemotherapy)
-
Radiotherapy
-
Pallidotomy
-
Aftercare (After-Treatment)
-
Deep Brain Stimulation
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.